Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Rheumatoid factor increased
Clinical narrative: had joint and muscle aches.; had joint and muscle aches; Subsequent blood test indication an high ANA titer of 1:640, nuclear, homogeneous, and a eheumatoid factor < 14; Subsequent blood test indication an high ANA titer of 1:640, nuclear, homogeneous, and a rheumatoid factor < 14; Pain in upper body; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 (Lot number: ER2613) at the age of 63 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: SERTRALINE HYDROCHLORIDE. Vaccination history included: Bnt162b2 (vaccine location=Left arm},, {product=COVID 19, brand=Pfizer,, lot number=EN6199,, lot unknown=False,, administration date=15Mar2021,, dose number=1,, vaccine location=Left arm}]), administration date: 15Mar2021, when the patient was 63 years old, for COVID-19 immunization. The following information was reported: ARTHRALGIA (non-serious) with onset 05May2021, outcome "not recovered", described as "had joint and muscle aches."; MYALGIA (non-serious) with onset 05May2021, outcome "not recovered", described as "had joint and muscle aches"; ANTINUCLEAR ANTIBODY INCREASED (non-serious) with onset 05May2021, outcome "not recovered", described as "Subsequent blood test indication an high ANA titer of 1:640, nuclear, homogeneous, and a eheumatoid factor < 14"; RHEUMATOID FACTOR INCREASED (non-serious) with onset 05May2021, outcome "not recovered", described as "Subsequent blood test indication an high ANA titer of 1:640, nuclear, homogeneous, and a rheumatoid factor < 14"; PAIN (non-serious) with onset 05May2021, outcome "unknown", described as "Pain in upper body". The events "had joint and muscle aches.", "had joint and muscle aches", "subsequent blood test indication an high ana titer of 1:640, nuclear, homogeneous, and a eheumatoid factor < 14", "subsequent blood test indication an high ana titer of 1:640, nuclear, homogeneous, and a rheumatoid factor < 14" and "pain in upper body" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of arthralgia, myalgia, antinuclear antibody increased, rheumatoid factor increased.  Additional information: The week of the second vaccination patient had joint and muscle aches. That went away and then reappeared 05May. Subsequent blood test indication an high ANA titer of 1:640, nuclear, homogeneous, and a rheumatoid factor < 14. I have tried homeopathic remedies which reduced most of the pain in my upper body but continue to have pain and my hips and leg muscles. ae resulted in: Doctor or other healthcare professional office/clinic visit. Per Dr. please defer this to patient's Rheumatologist. No covid prior to vaccination, No covid was tested post vaccination.  No follow-up attempts are possible. No further information is expected.